ImmuPharma (LON:IMM) Stock Crosses Below 200 Day Moving Average – Here’s What Happened

ImmuPharma plc (LON:IMM) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 6.06 and traded as low as GBX 4.38. ImmuPharma shares last traded at GBX 4.60, with a volume of 674,319 shares trading hands.

ImmuPharma Stock Up 4.5%

The stock has a market cap of £28.70 million, a price-to-earnings ratio of -5.17 and a beta of 2.98. The business has a 50-day moving average of GBX 4.52 and a 200-day moving average of GBX 6.06.

ImmuPharma (LON:IMM) last released its quarterly earnings data on Wednesday, May 27th. The company reported GBX (0.37) earnings per share (EPS) for the quarter. ImmuPharma had a net margin of 3,519.56% and a negative return on equity of 1,397.44%. Equities analysts anticipate that ImmuPharma plc will post -339.0000022 earnings per share for the current year.

About ImmuPharma

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.